UZH1
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-134673-5MG | 5 mg | 521,00 | Add | |
HY-134673-1ML | 10mM/1mL | 571,00 | Add | |
HY-134673-10MG | 10 mg | 875,00 | Add | |
HY-134673-25MG | 25 mg | 1'723,00 | Add | |
HY-134673-50MG | 50 mg | 2'801,00 | Add | |
HY-134673-100MG | 100 mg | 4'320,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
UZH1 is a racemate of UZH1a and UZH1b. UZH1a is a potent and selective METTL3 inhibitor, with an IC50 of 280 nM. UZH1b (IC50=28 µM) is essentially inactive. UZH1 can be used for epitranscriptomic modulation of cellular processes. UZH1 has antitumor activity. UZH1 also can be used as a chemical probe for studying METTL3[1].
Category | Biochemicals |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Cancer, Apoptosis |
Format | Solubility: DMSO : 125 mg/mL (ultrasonic) |
Grade | Clinical information: No Development Reported |
Purity | 99.88% |
Molecular Formula | C32H42N6O3 |
Molecular Weight | 558.71 |
CAS-Number | 2925713-02-4 |
Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |